Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The ...

Fast-changing news on tariffs flummoxed traders across asset classes Friday, shattering the calm spurred earlier by receding ...

The Swiss pharmaceutical company said the FDA backed a label expansion for the Pathway HER2 (4B5) test to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who could be ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...

Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Chris Rocheleau, Trump’s pick for acting head of the Federal Aviation Administration, has been a longtime agency official and ...

The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

Chris Rocheleau fills the vacancy left by former FAA Administrator Mike Whitaker, who stepped down then President Donald Trump took office again.

Two Massachusetts men were indicted for COVID-19 fraud, facing charges of wire fraud conspiracy and wire fraud after allegedly filing fake unemployment claims.